ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,478,908 | +160.8% | 132,400 | +399.6% | 0.00% | +300.0% |
| Q2 2023 | $567,100 | -61.3% | 26,500 | -26.8% | 0.00% | -75.0% |
| Q1 2023 | $1,463,928 | -44.4% | 36,200 | -36.0% | 0.00% | -42.9% |
| Q4 2022 | $2,633,032 | +8.7% | 56,600 | +21.2% | 0.01% | 0.0% |
| Q3 2022 | $2,422,000 | -11.1% | 46,700 | -18.9% | 0.01% | -12.5% |
| Q2 2022 | $2,723,000 | -36.2% | 57,600 | -4.0% | 0.01% | -27.3% |
| Q1 2022 | $4,271,000 | -41.7% | 60,000 | -38.8% | 0.01% | -38.9% |
| Q4 2021 | $7,328,000 | +57.7% | 98,000 | +19.8% | 0.02% | +50.0% |
| Q3 2021 | $4,647,000 | +39.8% | 81,800 | +8.3% | 0.01% | +33.3% |
| Q2 2021 | $3,323,000 | -16.3% | 75,500 | -6.2% | 0.01% | -18.2% |
| Q1 2021 | $3,970,000 | +3.8% | 80,500 | -11.3% | 0.01% | +10.0% |
| Q4 2020 | $3,823,000 | +5.0% | 90,800 | +14.2% | 0.01% | 0.0% |
| Q3 2020 | $3,640,000 | -19.8% | 79,500 | -12.1% | 0.01% | -23.1% |
| Q2 2020 | $4,539,000 | -4.2% | 90,400 | -1.8% | 0.01% | -27.8% |
| Q1 2020 | $4,737,000 | +47.2% | 92,100 | +76.8% | 0.02% | +157.1% |
| Q4 2019 | $3,219,000 | +94.9% | 52,100 | +89.5% | 0.01% | +75.0% |
| Q3 2019 | $1,652,000 | -30.6% | 27,500 | -2.5% | 0.00% | -33.3% |
| Q2 2019 | $2,380,000 | +134.9% | 28,200 | +166.0% | 0.01% | +100.0% |
| Q1 2019 | $1,013,000 | +34.9% | 10,600 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $751,000 | -34.4% | 10,600 | -20.9% | 0.00% | -33.3% |
| Q3 2018 | $1,145,000 | -79.2% | 13,400 | -71.8% | 0.00% | -80.0% |
| Q2 2018 | $5,517,000 | +62.7% | 47,600 | +13.6% | 0.02% | +66.7% |
| Q1 2018 | $3,390,000 | +74.6% | 41,900 | +26.6% | 0.01% | +80.0% |
| Q4 2017 | $1,942,000 | +243.1% | 33,100 | +173.6% | 0.01% | +150.0% |
| Q3 2017 | $566,000 | +103.6% | 12,100 | +45.8% | 0.00% | +100.0% |
| Q4 2016 | $278,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |